Wells Fargo Maintains Overweight on HealthEquity, Raises Price Target to $110
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stan Berenshteyn maintains an Overweight rating on HealthEquity (NASDAQ:HQY) and raises the price target from $107 to $110.
June 20, 2024 | 12:42 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo analyst Stan Berenshteyn maintains an Overweight rating on HealthEquity and raises the price target from $107 to $110.
The increase in price target from $107 to $110 and the maintained Overweight rating by a reputable analyst from Wells Fargo is likely to positively impact investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100